Pictilisib and pembrolizumab may prolong survival for women with advanced breast cancer, according to data from preliminary studies.
Although survival in male breast cancer has improved, treatment lags behind when compared to the cancer therapy women receive.
Home use of pneumatic compression devices to treat lymphedema can reduce annual treatment costs.
Cause-specific mortality similar for women and girls with pregnancy-associated MM or non-PAMM.
Adding tamoxifen to ovarian suppression doesn't provide a significant benefit over tamoxifen alone among premenopausal women with hormone receptor-positive early breast cancer, but the addition of ovarian suppression does benefit some of these women.
Two-thirds of breast-conserving surgical patients undergo six to seven weeks of radiation, but three weeks of higher-dose radiation could be more beneficial.
Improved progression-free survival in relapsed multiple myeloma has been seen with the addition of carfilzomib to lenalidomide and dexamethasone therapy.
Deleterious mutations were identified in 14.6 percent of patients in a cohort unselected for family history.
Researchers also found exercising seven hours or more a week boosted chances of living longer, whereas watching too much TV had the opposite effect.
Significant and durable improvements in insomnia and sleep quality, with and without armodafinil
Men receiving hormone therapy for prostate cancer may be missing out on protective meds, researchers say.
Using antacids to control acid reflux may improve survival chances for patients with head and neck cancer, but the reason for antacids benefit remains unclear.
Lower use of imaging seen in the VA than in fee-for-service Medicare; not associated with less geographic variation.
An experimental breast cancer vaccine boosts immune response and appears to slow spread in those with advanced disease.
Advances in treatment offer insight into lymphedema management, improvements in care
Significant improvements in breast cancer outcomes found despite similar patterns of relapse, research shows.
The largest number of obesity-related cancers are diagnosed in North America and Europe.
Across all patient groups and imaging services, more imaging is used by advanced practice clinicians (APCs) than primary care doctors.
New grading system for cancer-linked weight loss includes independent prognostic significance of BMI and percent weight loss.
Participants in prosocial versus standard group have higher level of depression, anxiety after intervention.
Better breast reconstruction outcomes may be one reason behind the trend of increasing mastectomy rates for early-stage breast cancer patients eligible for lumpectomy.
Nivolumab and dabrafenib plus trametinib up survival in melanoma without, with BRAF, respectively.
Proportion undergoing testing varies by demographic and health-related factors, and by state, a study found.
Research indicates smoking cessation boosts survival, even if there has been a weight gain.
Reduction in distress, unmet information needs with telephone-based, peer-support program
There has been an increase in physicians grading health care reform as "A" and a decrease in those grading it as a failure, according to recent survey data.
A video-based educational tool increased comprehension of prostate health terms in patients with a mean literacy level of 7th grade or higher.
Supply and manufacturing problems, plus fewer companies in the market are among the causes for soaring generic prices.
Findings based upon 21 months of follow-up from original SEAS lipid therapy trial did not find the lipid-lowering therapy ezetimibe/simvastatin to be associated with an increased risk of developing cancer.
Researchers found that non-hospice patients used significantly more health care resources, mainly for acute conditions not directly related to their cancer.
Active smokers more knowledgeable than former smokers or nonsmokers, and often cite urologist as source of information.
The rapidly escalating costs of skin cancer treatment outstripped other cancer type treatment costs, increasing five times faster. The findings underscore importance of prevention efforts.
In nursing students, dangerous drinking is prevalent, and more problem drinking among younger students and smokers.
Benefit seen in long-term smokers when CT testing is done by skilled experts.
Reasons behind this colorectal cancer trend are unclear, and it's happening even as rates decline among older Americans.
The CDC notes that more than half of cervical cancer cases occur among women never or rarely screened.
Pairing ipilimumab with sargramostim gives patients about five extra months survival time for patients with advanced melanoma, researchers report.
The endorsed guideline outlines use of adjuvant and salvage radiotherapy after surgery for prostate cancer.
Annual FIT IDs all colorectal cancer, and may be equivalent to colonoscopy in detecting advanced neoplasia in first-degree relatives of patients with colorectal cancer (CRC).
For patients not diagnosed with cancer, the median diagnostic cost per patient was about 28 times higher for those with versus without biopsy.
For black women and Hispanic women, obesity increases postmenopausal risk of estrogen receptor (ER)-negative and progesterone receptor-positive breast cancer.
Increased expression of a microRNA (miRNA) panel seems highly accurate for diagnosis of pancreatic ductal adenocarcinoma (PDAC), according to a study published online.
A significant absence of health insurer competition was seen in 72 percent of the metropolitan areas examined.
Cost is a key factor for women to maintain their hormone treatment regimen, researchers report.
The combined breast screening cost-effective over a range of incremental improvements in test performance.
The researchers found that the sensitivity, false-positive rate, and cancer detection rate of screening mammography increased with increasing numbers of radiologist work-ups for their own recalled mammograms.
Those who know they have greater risk of colorectal cancer were found no more likely to be screened than others at lower risk, according to research.
Mixed views have been expressed in relation to explaining the causal role of HPV in oropharyngeal cancer.
A majority of of palliative care clinicians report burnout, according to a study, with the greatest risk of burnout for younger clinicians and those working more than 50 hours per week
Health care is third most important issue to Americans in fall elections, according to polls
In cases of bladder cancer, omission of muscle in specimen or its mention in pathology report is linked to increased mortality.
Even a small daily dose of aspirin may help lower mortality among men with nonmetastatic prostate cancer, according to research.
Findings show benefits compared with FOLFIRI for patients with untreated metastatic disease.
Most patients use lifestyle-altering strategies and about 40 percent adopt a care-altering strategy to manage financial distress associated with their cancer care.
Findings among older patients with terminal ovarian cancer showed that an increase in hospice care did not offset intensive end-of-life care in older women.
Herceptin in addition to chemotherapy boosts survival, reduces risk of cancer recurrence
Among elderly patients with gastrointestinal cancer, unplanned hospitalizations are common, according to online research.
Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.
Many physicians believe digital communication technologies, including mobile apps, can be of benefit to their patients.
For some men, prostate cancer recurrence may be overdetected, especially in those aged over 70.
'Extra Help' program allows more women of varying racial and ethnic backgrounds to continue their hormone therapy.
In a study of more than 1.1 million cancer patients who had surgery, almost 5 percent died within one month of their operation. Lack of access to quality care a major factor in these deaths, researchers say.
Findings suggest that elevated levels of cholesterol and triglycerides may be linked with greater risk of the prostate cancer recurrence, but normalization of blood fats may reduce risk.
Fiber-based formulations seem to lower the odds for developing colorectal cancer, non-fiber products seem to raise them.
Preliminary finding may bring doctors one step closer to and ovarian cancer screening test.
Patients diagnosed with breast cancer, head and neck cancer, and malignant melanoma are particularly at risk for disorders such as anxiety or depression.
Presence of residual vein thrombosis may help determine the optimal duration of anticoagulant therapy in cancer patients with deep vein thrombosis (DVT) of the lower limbs.
No increased invasive cancer risk from bone morphogenetic protein exposure in men or women has been observed.
Low-dose computed tomography has been determined to be both an effective and low cost means of detecting lung cancer in Medicare beneficiaries.
Research suggests the human papillomavirus (HPV) vaccine could prevent 90 percent of cervical malignancies.
Doctors, hospitals received billions of dollars from drug and device makers in second half of 2013, according to the new Open Payments program (created under the Affordable Care Act).
Managing toxicity costs are higher for treatment with less-specific targeted agents and chemotherapies.
Risks of claims alleging failure to screen for esophageal cancer arising from acts of commission, omission are similarly low.
Tumors in rodents exposed to dim light seemed to develop resistance to a common cancer drug.
A higher obesity-driven risk of secondary cancer has been identified for kidney, pancreatic, esophageal, endometrial cancers.
Drug should remain standard of care for HER2-positive tumors, according to new research.
Studies show improved progression-free melanoma survival for both cobimetinib combined with vemurafenib, and dabrafenib combined with trametinib.
Certain conditions make it harder to reliably detect tumors, and regions with locally-endemic infectious lung diseases pose an added hurdle for lung cancer detection.
A report from the IMS Institute for Healthcare Informatics notes 10 "harbingers of change" expected to alter the delivery of health care and medicine use over the next decade.
Smokers with cancer who used e-cigarettes along with traditional cigarettes were more dependent on nicotine, and the long-term safety of the devices still unclear, researchers caution.
Findings based on comparison to sulfonylureas and thiazolidinediones
Chokeberry extract enhances cytotoxicity of gemcitabine on a single cancer cell line, according to research.
High rates of preserved sexual function seen with combination beam plus brachytherapy for prostate cancer.
Mammograms for those aged 69 to 75 could result in over-treatment, researchers caution.
About 14.5 million U.S. cancer survivors are alive today, but aging population and increasing obesity threaten progress.
For patients with advanced esophageal cancer, dysphagia is improved with radiotherapy alone, according to a study.
Shorter time to testosterone recovery with 18 versus 36 months androgen deprivation therapy.
More than 25% of hospital medicine services were rated by ordering physicians as at least a partially defensive order, according to recent data.
The addition of chest radiation reduces recurrence rate and, improves survival when added to chemo in extensive stage small-cell lung cancer.
As consumers take on more costs of care, access to data for informed decisions is deemed crucial.
For men with early-stage prostate cancer, watching waiting is not always the best course of action, especially for black patients.
Compared with staff from other wards, palliative care staff reported much better conditions for the dying, with 95 percent indicating that patients die with dignity in palliative care wards.
Olaparib has been deemed safe in combination with carboplatin/paclitaxel in advanced ovarian cancer.
Prediabetes has been linked to an increased risk of cancer overall and with increased risks of site-specific cancers, including liver, endometrial, and stomach/colorectal cancer.
Recommendations are for men whose tumors have grown resistant to hormonal therapies were issued jointly by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) in Canada.
Insurance coverage under ACA, population aging, and economic growth will likely drive future spending increases.
Study raises questions about the effect of soy's estrogen-like properties.
New multiple myeloma treatment options have shown promise for patients aged 65 years and younger and for newly diagnosed individuals ineligible for stem-cell transplantation, according to two studies.
Airline pilots and cabin crew have an increased incidence of melanoma, nearly twice that of the general population, according to a meta-analysis published online.
Women overdue for mammogram respond better to postcard plus reminder letter from family physician.
- Key discovery in understanding successes and failures of immunotherapy
- Researchers identify biological indicator of response to new ovarian cancer drug
- Managing obesity should be part of cancer care
- Galeterone active in one form of castration-resistant prostate cancer
- Reducing side effects of everolimus administration
- Navigation and survivorship: Rationalizing your program costs
- Monitoring psychosocial function in radiotherapy
- Comparison of medications for managing nausea and vomiting
- Comparison of constipation management medications
- Chemo- and immunotherapy combination is a promising treatment for pancreatic cancer
- High tumor immune cell levels may identify women with HER2+ breast cancer who may benefit from chemotherapy alone
- Hair Dyes and Cancer Risk (Fact Sheet)
- For bladder cancer, laparoscopic radical cystectomy effective at preventing recurrence
- Aspirin and/or NSAID use may improve risk of high-grade prostate cancer
- Modifying lifestyle, HPV vaccine can help prevent anal cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|